Richard Paul Schottenfeld

Richard Paul Schottenfeld appears in our data through filings on Acasti Pharma Inc. shares, published by SEDI. In total, 15 filings cover trades dated from 12 July 2016 to 5 October 2018.

Market trades split into 3 purchases (€370k) and 10 sales (€242k). Purchases outweigh sales by €129k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at 3 purchases and 2 sales.

In size, the median ticket on the buying side is €134k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 9 October 2018, reports a transaction in Acasti Pharma Inc. The last insider purchase was made public on 9 October 2018, 2,941 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.